Twist Bioscience Corp
Company Stats
- Market Cap
- $12.1B
- as of Sep 30, 2026
- Shares Outstanding
- 62.7M
- Free Float
- 96.9%
Income Statement
- Revenue
- $376.6M
- Operating Income
- -$136.3M
- Net Income
- -$77.7M
- EBITDA
- -$111.4M
- Revenue Growth, 3Y
- 22.8%
- FCF Margin, 3Y Avg
- -37.2%
- FCF Margin, Worst Year
- -69.5%
Cash Flow
- Free Cash Flow
- -$75.6M
- FCF Yield
- -0.6%
- Owner FCF Yield
- -1.2%
Balance Sheet
- Cash & Equivalents
- $183.0M
Returns & Capital
- SBC, 3Y Avg
- $48.6M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $376.6M | -$75.6M | -20.1% |
| FY2024 | $313.0M | -$69.2M | -22.1% |
| FY2023 | $245.1M | -$170.3M | -69.5% |
| FY2022 | $203.6M | -$226.2M | -111.1% |
| FY2021 | $132.3M | -$139.3M | -105.3% |
Annual filing data through FY ended September 30, 2025; shares and float as of October 31, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back